418 related articles for article (PubMed ID: 24980054)
41. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
42. Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
Castera-Ducros C; Paloque L; Verhaeghe P; Casanova M; Cantelli C; Hutter S; Tanguy F; Laget M; Remusat V; Cohen A; Crozet MD; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2013 Nov; 21(22):7155-64. PubMed ID: 24080103
[TBL] [Abstract][Full Text] [Related]
43. Antiprotozoal activity of Khaya anthotheca, (Welv.) C.D.C. a plant used by chimpanzees for self-medication.
Obbo CJ; Makanga B; Mulholland DA; Coombes PH; Brun R
J Ethnopharmacol; 2013 May; 147(1):220-3. PubMed ID: 23501156
[TBL] [Abstract][Full Text] [Related]
44. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
Jain SK; Sahu R; Walker LA; Tekwani BL
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
[TBL] [Abstract][Full Text] [Related]
45. 8,8-dialkyldihydroberberines with potent antiprotozoal activity.
Endeshaw M; Zhu X; He S; Pandharkar T; Cason E; Mahasenan KV; Agarwal H; Li C; Munde M; Wilson WD; Bahar M; Doskotch RW; Kinghorn AD; Kaiser M; Brun R; Drew ME; Werbovetz KA
J Nat Prod; 2013 Mar; 76(3):311-5. PubMed ID: 23167812
[TBL] [Abstract][Full Text] [Related]
46. Tyrosol and hydroxytyrosol derivatives as antitrypanosomal and antileishmanial agents.
Belmonte-Reche E; Martínez-García M; Peñalver P; Gómez-Pérez V; Lucas R; Gamarro F; Pérez-Victoria JM; Morales JC
Eur J Med Chem; 2016 Aug; 119():132-40. PubMed ID: 27155468
[TBL] [Abstract][Full Text] [Related]
47. Potent and selective antiplasmodial activity of the cyanobacterial alkaloid nostocarboline and its dimers.
Barbaras D; Kaiser M; Brun R; Gademann K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4413-5. PubMed ID: 18606541
[TBL] [Abstract][Full Text] [Related]
48. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
Agarwal KC; Sharma V; Shakya N; Gupta S
Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Sankaranarayanan M
Eur J Med Chem; 2018 Apr; 150():559-566. PubMed ID: 29549840
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and anti-leishmanial evaluation of 1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline derivatives against Leishmania infantum.
Ashok P; Chander S; Tejería A; García-Calvo L; Balaña-Fouce R; Murugesan S
Eur J Med Chem; 2016 Nov; 123():814-821. PubMed ID: 27541264
[TBL] [Abstract][Full Text] [Related]
51. Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Paloque L; Hutter S; Castera-Ducros C; Laget M; Rault S; Valentin A; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2015 May; 23(10):2377-86. PubMed ID: 25846065
[TBL] [Abstract][Full Text] [Related]
52. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
53. Design, Synthesis and Biological Evaluation of 7-arylbenzo[c]acridine-5,6- diones as Potential Anti-Leishmanial and anti-trypanosomal Agents.
Mahajan S; Khan SI; Tekwani BL; Khan IA; Singh IP
Med Chem; 2018; 14(6):563-572. PubMed ID: 29485004
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives.
Guillon J; Cohen A; Das RN; Boudot C; Gueddouda NM; Moreau S; Ronga L; Savrimoutou S; Basmaciyan L; Tisnerat C; Mestanier S; Rubio S; Amaziane S; Dassonville-Klimpt A; Azas N; Courtioux B; Mergny JL; Mullié C; Sonnet P
Chem Biol Drug Des; 2018 May; 91(5):974-995. PubMed ID: 29266861
[TBL] [Abstract][Full Text] [Related]
55. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Hutter S; Castera-Ducros C; Laget M; Remusat V; M'Rabet MK; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2015 Mar; 92():282-94. PubMed ID: 25559208
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis and biological evaluation of 1,3,6-trisubstituted β-carboline derivatives for cytotoxic and anti-leishmanial potential.
Lunagariya NA; Gohil VM; Kushwah V; Neelagiri S; Jain S; Singh S; Bhutani KK
Bioorg Med Chem Lett; 2016 Feb; 26(3):789-794. PubMed ID: 26791014
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity.
Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S
Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885
[TBL] [Abstract][Full Text] [Related]
58. Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds.
Alkhaldi AA; de Koning HP; Bukhari SNA
Drug Des Devel Ther; 2019; 13():1179-1185. PubMed ID: 31118564
[No Abstract] [Full Text] [Related]
59. Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives.
Guillon J; Cohen A; Boudot C; Valle A; Milano V; Das RN; Guédin A; Moreau S; Ronga L; Savrimoutou S; Demourgues M; Reviriego E; Rubio S; Ferriez S; Agnamey P; Pauc C; Moukha S; Dozolme P; Nascimento SD; Laumaillé P; Bouchut A; Azas N; Mergny JL; Mullié C; Sonnet P; Courtioux B
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):432-459. PubMed ID: 31899980
[TBL] [Abstract][Full Text] [Related]
60. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites.
Werbovetz KA; Sackett DL; Delfín D; Bhattacharya G; Salem M; Obrzut T; Rattendi D; Bacchi C
Mol Pharmacol; 2003 Dec; 64(6):1325-33. PubMed ID: 14645662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
